UBX

Unity Biotechnology

Delisted

UBX was delisted on the 8th of July, 2025.

46 hedge funds and large institutions have $5.24M invested in Unity Biotechnology in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

97% less capital invested

Capital invested by funds: $153M → $5.24M (-$148M)

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.28M
Puts
$49K
Net Calls
Net Calls Change

Top Buyers

1 +$347K
2 +$131K
3 +$61.1K
4
BlackRock
BlackRock
New York
+$60.4K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$52K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.64M
2
$854K
3
$469K
4
$347K
5
$256K
6
$200K
7
$175K
8
$153K
9
$142K
10
$126K
11
$114K
12
$111K
13
$81.5K
14
$80.2K
15
$77.3K
16
$67.2K
17
$63.1K
18
$62.2K
19
$46.1K
20
$35.9K
21
$31.9K
22
$23.5K
23
$21.5K
24
$17.3K
25
$17.2K